Danaher has agreed to sell three of its life sciences tools businesses to Sartorius Stedim Biotech for approximately $750 million cash, the companies said today—a deal that according to Danaher was prompted by its planned $21.4 billion acquisition of GE Life Sciences’ Biopharma business.
Sartorius has agreed to acquire Danaher’s label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards businesses. Sartorius said the three Danaher businesses employ around 300 people worldwide combined, and enjoyed a “strong” growth profile and double-digit profit margins.
{iframe}https://www.genengnews.com/news/danaher-selling-off-some-businesses-to-sartorius-for-750m-tying-the-deal-to-ge-biopharma-acquisition/?utm_medium=newsletter&utm_source=GEN+Daily+News+Highlights&utm_content=01&utm_campaign=GEN+Daily+News+Highlights_20191106&oly_enc_id=5901D8426578G1Y{/iframe}